✨ Your Portfolio is fetched and updated from zerodha.

Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (231 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
41.33
4,51,075
65.64
1,49,124
29.81
1,15,641
26.59
1,11,589
19.50
1,03,966
58.09
1,03,368
20.60
1,01,755
25.17
87,777
180
69,707
61.60
65,610
27.66
65,584
38.25
59,359
39.90
41,331
44.77
40,739
37.56
39,663
48.37
34,314
34.97
32,324
117
25,120
31.28
22,595
13.78
21,452
105
21,221
-
21,030
44.10
19,038
30.59
18,199
22.86
15,424
43.71
15,197
23.69
15,194
93.92
12,619
30.98
12,427
37.98
11,870
55.20
11,427
43.35
11,180
58.78
10,881
20.80
10,637
127
9,806
26.12
9,410
62.37
9,359
29.90
8,775
31.91
8,143
23.95
7,420
52.81
7,324
27.47
5,953
-
5,571
-
5,309
34.72
4,893
-
4,183
24.15
4,075
84.72
4,049
32.97
3,797
41.83
3,748
191
3,621
33.44
3,397
16.57
3,357
26.83
3,109
22.79
2,943
56.84
2,844
8.87
2,617
-
2,370
7.24
2,306
23.12
2,299
149
2,130
-
2,077
31.55
1,784
24.68
1,647
27.85
1,613
28.04
1,560
50.85
1,550
41.30
1,450
32.18
1,386
62.61
1,380
39.92
1,305
14.71
1,292
18.61
1,283
21.10
1,267
15.99
1,220
4.68
1,163
47.66
1,105
25.18
1,068
24.13
1,059
45.01
959
-
902
20.73
891
44.08
884
9.90
869
-
863
18.87
789
45.52
753
31.00
722
34.66
711
50.32
673
35.25
637
20.54
535
75.84
530
15.24
529
25.57
514
48.00
504
24.48
485
-
413
19.72
391
40.32
380
31.45
365
43.70
351
33.78
326
35.34
320
68.67
317
63.97
314
15.89
303
-
287
-
275
-
268
24.26
258
75.09
258
43.04
251
25.45
250
22.46
248
-
245
27.54
237
28.76
236
13.14
231
-
219
20.54
214
-
205
30.81
205
38.85
197
39.95
192
34.97
187
14.84
186
13.31
181
660
171
17.55
169
13.70
168
56.50
167
24.67
167
6.77
164
11.63
163
35.71
161
-
159
601
151
31.09
150
17.26
148
12.66
148
20.64
139
6.37
138
13.75
133
38.44
132
35.17
130
15.47
126
-
125
15.32
123
188
107
-
106
16.98
104
11.47
100
26.25
98
77.76
94
-
92
19.34
91
110
82
-
75
9.82
70
25.25
70
6.47
69
-
66
15.11
65
-
65
13.54
61
-
61
3.44
61
13.78
59
-
55
7.49
54
12.25
52
15.56
52
20.91
52
18.91
52
126
51
-
48
210
47
-
46
-
45
56.38
45
99.65
44
18.38
43
22.07
43
37.45
39
-
38
23.90
37
49.08
37
-
36
-
35
-
32
13.77
31
6.26
30
7.11
29
118
29
-
28
320
27
6.32
26
-
25
29.03
25
7.14
24
11.16
24
26.27
23
10.69
22
-
21
-
17
36.02
16
23.52
15
51.21
15
95.74
13
29.32
13
12.96
13
-
13
-
12
-
12
-
12
22.12
11
825
11
8.67
9
63.51
9
-
8
-
8
89.76
7
824
7
-
6
-
6
-
5
51.31
5
69.81
4
-
3
-
2
Showing 5 231 of 231 Show More
Market Share

    Select a Metric
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Fermentation Based API Products - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Vaccines - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • Fermentation Capacity (KL)
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Benzimidazole (%)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Results
        Timeline
        Watchlist
        Portfolio
        Alerts
        Stock Screener
        Market
        Raw Material